Cargando…

Economic Burden of Treatment‐Resistant Depression Among Patients Hospitalized for Major Depressive Disorder in the United States

OBJECTIVES: This study aimed to evaluate hospital length of stay (LOS) and cost as well as readmission risk and the associated economic burden among patients hospitalized for treatment‐resistant and non–treatment‐resistant major depressive disorder. METHODS: Adult patients with a primary hospital di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Jay, Szukis, Holly, Sheehan, John J., Alphs, Larry, Menges, Brandy, Lingohr‐Smith, Melissa, Benson, Carmela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Psychiatric Association 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175799/ https://www.ncbi.nlm.nih.gov/pubmed/36101876 http://dx.doi.org/10.1176/appi.prcp.20190001

Ejemplares similares

An episode level evaluation of the treatment journey of patients with major depressive disorder and treatment-resistant depression
por: Wu, Bingcao, et al.
Publicado: (2019)

The Health-Related Quality of Life, Work Productivity, Healthcare Resource Utilization, and Economic Burden Associated with Levels of Suicidal Ideation Among Patients Self-Reporting Moderately Severe or Severe Major Depressive Disorder in a National Survey
por: Benson, Carmela, et al.
Publicado: (2021)

US Integrated Delivery Networks Perspective on Economic Burden of Patients with Treatment-Resistant Depression: A Retrospective Matched-Cohort Study
por: Pilon, Dominic, et al.
Publicado: (2019)

The Economic Burden of Adults with Major Depressive Disorder in the United States (2019)
por: Greenberg, Paul, et al.
Publicado: (2023)

The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018)
por: Greenberg, Paul E., et al.
Publicado: (2021)

Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States
por: Amin, Alpesh, et al.
Publicado: (2015)

Venous Thromboembolism Prophylaxis and Risk for Acutely Medically Ill Patients Stratified by Different Ages and Renal Disease Status
por: Amin, Alpesh, et al.
Publicado: (2019)

Influence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illnesses in the USA
por: Amin, Alpesh, et al.
Publicado: (2019)

Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States
por: Baker, Christine L., et al.
Publicado: (2018)

Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USA
por: Aly, Abdalla, et al.
Publicado: (2021)

The clinical, economic, and patient‐centric burden of insomnia symptom severity in adults with major depressive disorder in the United States
por: Joshi, Kruti, et al.
Publicado: (2023)

All-Cause, Stroke/Systemic Embolism–, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants
por: Deitelzweig, Steve, et al.
Publicado: (2018)

Economic burden of relapse/recurrence in patients with major depressive disorder
por: Gauthier, Genevieve, et al.
Publicado: (2019)

Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United States
por: Deitelzweig, Steven, et al.
Publicado: (2018)

The Increasing Economic Burden with Additional Steps of Pharmacotherapy in Major Depressive Disorder
por: Arnaud, Alix, et al.
Publicado: (2021)

Humanistic and economic burden associated with depression in the United States: a cross-sectional survey analysis
por: Jain, Saundra, et al.
Publicado: (2022)

Projecting the Potential Effect of Using Paliperidone Palmitate Once-Monthly and Once-Every-3-Months Long-Acting Injections Among Medicaid Beneficiaries with Schizophrenia
por: Basu, Anirban, et al.
Publicado: (2018)

Clinically meaningful changes on depressive symptom measures and patient‐reported outcomes in patients with treatment‐resistant depression
por: Turkoz, Ibrahim, et al.
Publicado: (2021)

Economic burden of major depressive disorder: a case study in Southern Iran
por: Keshavarz, Khosro, et al.
Publicado: (2022)

Economic and Humanistic Burden Associated with Depression and Anxiety Among Adults with Non-Communicable Chronic Diseases (NCCDs) in the United States
por: Armbrecht, Eric, et al.
Publicado: (2021)

Treatment Patterns and Antipsychotic Medication Adherence Among Commercially Insured Patients With Schizoaffective Disorder in the United States
por: Joshi, Kruti, et al.
Publicado: (2016)

Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States
por: McComsey, Grace A., et al.
Publicado: (2021)

Economic Burden of Sanfilippo Syndrome in the United States
por: Ashby, Frederick, et al.
Publicado: (2023)

Childhood maltreatment, depression and their link to adult economic burdens
por: Petersen, Julia, et al.
Publicado: (2022)

The prevalence and economic burden of treatment-resistant depression in Thailand
por: Prasartpornsirichoke, Jirada, et al.
Publicado: (2023)

Estimated Human and Economic Burden of Four Major Adult Vaccine-Preventable Diseases in the United States, 2013
por: McLaughlin, John M., et al.
Publicado: (2015)

Treatment-resistant depression and major depression with suicide risk—The cost of illness and burden of disease
por: Sousa, Rute Dinis, et al.
Publicado: (2022)

The similarity of the structure of DSM-IV criteria for major depression in depressed women from China, the United States and Europe
por: Kendler, K. S., et al.
Publicado: (2015)

Economic Burden of West Nile Virus in the United States
por: Barrett, Alan D. T.
Publicado: (2014)

The Economic Burden of Obesity by Glycemic Stage in the United States
por: Li, Qian, et al.
Publicado: (2015)

The potential economic burden of Zika in the continental United States
por: Lee, Bruce Y., et al.
Publicado: (2017)

Economic Burden of Legionnaires’ Disease, United States, 2014
por: Baker-Goering, Madeleine, et al.
Publicado: (2021)

Incremental Health Care Resource Utilization and Economic Burden of Venous Thromboembolism Recurrence from a U.S. Payer Perspective
por: Lin, J., et al.
Publicado: (2014)

Introduction to the Special Issue of PharmacoEconomics on Major Depressive Disorders
por: Greenberg, Paul E., et al.
Publicado: (2021)

P1703: ECONOMIC BURDEN OF TRANSFUSION-DEPENDENT BETA-THALASSEMIA IN THE UNITED STATES
por: Udeze, C., et al.
Publicado: (2022)

The Projected Economic and Health Burden of Uncontrolled Asthma in the United States
por: Yaghoubi, Mohsen, et al.
Publicado: (2019)

Regarding “The Clinical and Economic Burden of Norovirus Gastroenteritis in the United States”
por: Do, Steven R, et al.
Publicado: (2021)

The national economic burden of rare disease in the United States in 2019
por: Yang, Grace, et al.
Publicado: (2022)

The Economic Burden of Eosinophilic Gastritis and Eosinophilic Enteritis in the United States
por: Woolley, Michael, et al.
Publicado: (2022)

The economic and humanistic burden of bipolar disorder in adults in the United States
por: Dembek, Carole, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fkrdis1gl4n1b42qumnvocfgh0